Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects

Conditions:   Metabolic Syndrome;   Obesity Interventions:   Drug: coated beads glucose (8 g) and caffeine anhydrous;   Drug: coated beads glucose (8 g);   Drug: uncoated beads glucose (8 g) and caffeine anhydrous Sponsors:   Aphaia Pharma US LLC;   ACC GmbH Analytical Clinical Concepts, Germany;   Nova-Clin Medical Research Center S.R.L., Romania;   BioClinica, Inc.;   Galephar Pharmaceutical Research (PR), Inc, Puerto Rico Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials